Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim for PBPC Mobilization in Solid Tumors
NCT00117442Phase 2Completed
- Sponsor
- Amgen
- Start
- Aug 2002
- Primary completion
- Aug 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of pegfilgrastim in breast cancer, lung cancer, ovarian cancer, sponsored by Amgen. Started Aug 2002; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
breast cancerlung cancerovarian cancer
Beyond the preview
Go deeper on NCT00117442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117442.